Intellectual Property,
Civil Litigation
Dec. 2, 2021
Jury awards $8M in Illumina patent case against Chinese company
Due to the jury’s finding of willful infringement in the DNA sequencing infringement case, Illumina could pursue treble damages.
Edward Reines
Jury awards $8M in Illumina patent case against Chinese company
A San Francisco federal jury has awarded $8 million in damages against a Chinese company for infringing four patents of Illumina Inc. over DNA sequencing products.
The jury on Tuesday afternoon rejected arguments by defendant BGI Genomics Co. Ltd. and its subsidiaries that four of the patents were invalid. It found a fifth patent invalid. Illumi...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
